BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15956280)

  • 41. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.
    Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C
    Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Shinoda K; Nakagawa K; Kosaka T; Tanaka N; Maeda T; Kono H; Mizuno R; Kikuchi E; Miyajima A; Umezawa K; Oya M
    Hum Immunol; 2010 Aug; 71(8):763-70. PubMed ID: 20573582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ).
    Horiuchi K; Morioka H; Nishimoto K; Suzuki Y; Susa M; Nakayama R; Kawai A; Sonobe H; Takaishi H; Ozaki T; Yabe H; Umezawa K; Toyama Y
    Cancer Lett; 2008 Dec; 272(2):336-44. PubMed ID: 18760530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
    Suzuki K; Aiura K; Matsuda S; Itano O; Takeuchi O; Umezawa K; Kitagawa Y
    Clin Exp Metastasis; 2013 Apr; 30(4):381-92. PubMed ID: 23111540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
    Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
    J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
    Sato M; Nakanishi K; Haga S; Fujiyoshi M; Baba M; Mino K; ; Niwa H; Yokoo H; Umezawa K; Ohmiya Y; Kamiyama T; Todo S; Taketomi A; Ozaki M
    Oncol Res; 2013; 21(6):333-43. PubMed ID: 25198663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dimethyl Fumarate Induces Apoptosis
    Maeta T; Sato T; Asano K; Ito S
    Anticancer Res; 2022 May; 42(5):2301-2309. PubMed ID: 35489748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.
    Okudaira T; Hirashima M; Ishikawa C; Makishi S; Tomita M; Matsuda T; Kawakami H; Taira N; Ohshiro K; Masuda M; Takasu N; Mori N
    Int J Cancer; 2007 May; 120(10):2251-61. PubMed ID: 17278100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
    Uota S; Zahidunnabi Dewan M; Saitoh Y; Muto S; Itai A; Utsunomiya A; Watanabe T; Yamamoto N; Yamaoka S
    Cancer Sci; 2012 Jan; 103(1):100-6. PubMed ID: 21951590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Pugkhem A; Hahnvajanawong C; Chaiyagool J; Umezawa K; Okada S; Wongkham S
    PLoS One; 2014; 9(8):e106056. PubMed ID: 25170898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
    Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells.
    Meng Z; Mitsutake N; Nakashima M; Starenki D; Matsuse M; Takakura S; Namba H; Saenko V; Umezawa K; Ohtsuru A; Yamashita S
    Endocrinology; 2008 Nov; 149(11):5357-65. PubMed ID: 18653704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer.
    Kozakai N; Kikuchi E; Hasegawa M; Suzuki E; Ide H; Miyajima A; Horiguchi Y; Nakashima J; Umezawa K; Shigematsu N; Oya M
    Br J Cancer; 2012 Aug; 107(4):652-7. PubMed ID: 22805327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis.
    Ukaji T; Lin Y; Okada S; Umezawa K
    Biochem Biophys Res Commun; 2017 Mar; 485(1):76-81. PubMed ID: 28188787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor.
    Sanda T; Asamitsu K; Ogura H; Iida S; Utsunomiya A; Ueda R; Okamoto T
    Leukemia; 2006 Apr; 20(4):590-8. PubMed ID: 16453001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
    Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
    Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
    Matsuda T; Almasan A; Tomita M; Uchihara JN; Masuda M; Ohshiro K; Takasu N; Yagita H; Ohta T; Mori N
    J Virol; 2005 Feb; 79(3):1367-78. PubMed ID: 15650163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.
    Edwards DC; McKinnon KM; Fenizia C; Jung KJ; Brady JN; Pise-Masison CA
    Viruses; 2011 Oct; 3(10):1815-35. PubMed ID: 22069517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.